218 related articles for article (PubMed ID: 28869600)
21. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.
Du WW; Fang L; Yang W; Wu N; Awan FM; Yang Z; Yang BB
Cell Death Differ; 2017 Feb; 24(2):357-370. PubMed ID: 27886165
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA 195-5p Targets
Bai Y; Pan B; Zhan X; Silver H; Li J
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201585
[TBL] [Abstract][Full Text] [Related]
23. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
Qi W; Weber CR; Wasland K; Savkovic SD
BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
[TBL] [Abstract][Full Text] [Related]
24. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.
Tanos R; Karmali D; Nalluri S; Goldsmith KC
BMC Cancer; 2016 Feb; 16():97. PubMed ID: 26874859
[TBL] [Abstract][Full Text] [Related]
25. BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery.
Hagenbuchner J; Kuznetsov AV; Obexer P; Ausserlechner MJ
Oncogene; 2013 Oct; 32(40):4748-57. PubMed ID: 23146905
[TBL] [Abstract][Full Text] [Related]
26. GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis.
Asselin-Labat ML; David M; Biola-Vidamment A; Lecoeuche D; Zennaro MC; Bertoglio J; Pallardy M
Blood; 2004 Jul; 104(1):215-23. PubMed ID: 15031210
[TBL] [Abstract][Full Text] [Related]
27. Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression.
Li Z; Zhao J; Tikhanovich I; Kuravi S; Helzberg J; Dorko K; Roberts B; Kumer S; Weinman SA
Cell Death Differ; 2016 Apr; 23(4):583-95. PubMed ID: 26470730
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
Feng Q; He P; Wang Y
Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
[TBL] [Abstract][Full Text] [Related]
30. FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms.
Czymai T; Viemann D; Sticht C; Molema G; Goebeler M; Schmidt M
J Biol Chem; 2010 Apr; 285(14):10163-78. PubMed ID: 20123982
[TBL] [Abstract][Full Text] [Related]
31. Combination of vorinostat and flavopiridol is selectively cytotoxic to multidrug-resistant neuroblastoma cell lines with mutant TP53.
Huang JM; Sheard MA; Ji L; Sposto R; Keshelava N
Mol Cancer Ther; 2010 Dec; 9(12):3289-301. PubMed ID: 21159612
[TBL] [Abstract][Full Text] [Related]
32. FOXO3 longevity interactome on chromosome 6.
Donlon TA; Morris BJ; Chen R; Masaki KH; Allsopp RC; Willcox DC; Elliott A; Willcox BJ
Aging Cell; 2017 Oct; 16(5):1016-1025. PubMed ID: 28722347
[TBL] [Abstract][Full Text] [Related]
33. RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.
Singhal SS; Nagaprashantha L; Singhal P; Singhal S; Singhal J; Awasthi S; Horne D
Pharm Res; 2017 Aug; 34(8):1673-1682. PubMed ID: 28386633
[TBL] [Abstract][Full Text] [Related]
34. The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.
Yi JS; Sias-Garcia O; Nasholm N; Hu X; Iniguez AB; Hall MD; Davis M; Guha R; Moreno-Smith M; Barbieri E; Duong K; Koach J; Qi J; Bradner JE; Stegmaier K; Weiss WA; Gustafson WC
Neoplasia; 2021 Jun; 23(6):624-633. PubMed ID: 34107377
[TBL] [Abstract][Full Text] [Related]
35. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.
Gao Z; Li Z; Liu Y; Liu Z
Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608
[TBL] [Abstract][Full Text] [Related]
36. The DNA methylation of FOXO3 and TP53 as a blood biomarker of late-onset asthma.
Yuan L; Wang L; Du X; Qin L; Yang M; Zhou K; Wu M; Yang Y; Zheng Z; Xiang Y; Qu X; Liu H; Qin X; Liu C
J Transl Med; 2020 Dec; 18(1):467. PubMed ID: 33298101
[TBL] [Abstract][Full Text] [Related]
37. Interaction of transcription factor FoxO3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis.
Fusi L; Paudel R; Meder K; Schlosser A; Schrama D; Goebeler M; Schmidt M
J Biol Chem; 2022 Mar; 298(3):101714. PubMed ID: 35151693
[TBL] [Abstract][Full Text] [Related]
38. FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage.
Chung YM; Park SH; Tsai WB; Wang SY; Ikeda MA; Berek JS; Chen DJ; Hu MC
Nat Commun; 2012; 3():1000. PubMed ID: 22893124
[TBL] [Abstract][Full Text] [Related]
39. SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.
Bollinger LM; Witczak CA; Houmard JA; Brault JJ
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C278-87. PubMed ID: 24920680
[TBL] [Abstract][Full Text] [Related]
40. FOXO3 Is Expressed in Ovarian Tissues and Acts as an Apoptosis Initiator in Granulosa Cells of Chickens.
Cui C; Han S; Yin H; Luo B; Shen X; Yang F; Liu Z; Zhu Q; Li D; Wang Y
Biomed Res Int; 2019; 2019():6902906. PubMed ID: 31380433
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
